Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
Knowledge Portal > News > Posts > Rose’s patient profiled by UW Carbone Cancer Center
July 22
Rose’s patient profiled by UW Carbone Cancer Center

 
In a new profile published by UW Health and the UW Carbone Cancer Center, a grateful patient who worked with Professor Stephen Rose, MD, director of the UW Ob-Gyn Division of Gynecologic Oncology, shared her cervical cancer treatment story.

In “A Remarkable Outcome”, Rose and patient Phyllis Stokes share her clinical experiences with cervical cancer and multiple treatment modalities. After less-than-ideal results with chemotherapy, Rose recommended Phyllis start immunotherapy treatment. What happened next was remarkable:

“Rose said her response was even better than he expected. Prior to the advent of immunotherapy, the average lifespan of someone diagnosed with stage IV cervical cancer was about a year. And even though immunotherapy has been a significant advancement in treatment, it’s still not a guarantee.

“Even being PD-L1 positive, many patients still don’t have a response to pembrolizumab,” he said. “For her to have those treatments for two years and then have no evidence of cancer anywhere is just remarkable.””

You can read the whole story here. Join the Department of Ob-Gyn and Division of Gynecologic Oncology at the 2022 Sparkle of Hope Gala on September 16 to celebrate the entire gynecologic cancer community, including remarkable patients like Phyllis!

Comments

There are no comments for this post.